KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Insulet (PODD) EBT (2016 - 2025)

Insulet (PODD) has disclosed EBT for 16 consecutive years, with $140.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 25.97% year-over-year to $140.2 million, compared with a TTM value of $339.5 million through Dec 2025, up 13.09%, and an annual FY2025 reading of $339.5 million, up 13.09% over the prior year.
  • EBT was $140.2 million for Q4 2025 at Insulet, up from $122.8 million in the prior quarter.
  • Across five years, EBT topped out at $140.2 million in Q4 2025 and bottomed at -$36.1 million in Q2 2022.
  • Average EBT over 5 years is $44.2 million, with a median of $31.4 million recorded in 2021.
  • The sharpest move saw EBT crashed 263.22% in 2021, then surged 9666.67% in 2022.
  • Year by year, EBT stood at $33.4 million in 2021, then plummeted by 33.23% to $22.3 million in 2022, then skyrocketed by 383.86% to $107.9 million in 2023, then rose by 3.15% to $111.3 million in 2024, then grew by 25.97% to $140.2 million in 2025.
  • Business Quant data shows EBT for PODD at $140.2 million in Q4 2025, $122.8 million in Q3 2025, and $28.4 million in Q2 2025.